WHO | HIV drug resistance report 2017

WHO | HIV drug resistance report 2017

HIV drug resistance report 2017

Authors:
World Health Organization, United States Centers for Disease Control and Prevention, The Global Fund to Fight AIDS, Tuberculosis and Malaria

Publication details

Number of pages: 82
Publication date: July 2017
Languages: English
WHO reference number: 978-92-4-151283-1

Downloads

• HIV drug resistance report 2017
  pdf, 5 MB
• Access guidelines
• Access Global Action Plan
• Access policy brief: Tackling HIV drug resistance: trends, guidelines and global action

Overview

This second HIVDR report provides an update on recent population levels of HIVDR covering the period 2014–2016. The report includes data from 16 nationally representative surveys from 14 countries estimating resistance in: adults initiating ART (PDR), children younger than 18 months newly diagnosed with HIV, and adults on ART (acquired HIV drug resistance or ADR).

To contextualize results from representative HIVDR surveys, the report is supported by systematic reviews of the published literature on PDR in adults, children and adolescents, and ADR in paediatric and adult populations.

Finally, the report includes the prevalence of transmitted HIV drug resistance (TDR) in recently infected people in Malawi and Zimbabwe, estimated as part of recent household Population-based HIV Impact Assessment (PHIA) surveys, supported by the United States President’s Emergency Plan for AIDS Relief (PEPFAR).

Related links

• HIV drug resistance
• Treatment and care
• HIV service delivery
• HIV drug resistance: publications
• Publications on treatment and care
• Publications on HIV service delivery
• Toolkits, manuals, guides, reports and policy briefs